Cargando…

Mechanistic insights into synergy between nalidixic acid and tetracycline against clinical isolates of Acinetobacter baumannii and Escherichia coli

The increasing prevalence of antimicrobial resistance has become a global health problem. Acinetobacter baumannii is an important nosocomial pathogen due to its capacity to persist in the hospital environment. It has a high mortality rate and few treatment options. Antibiotic combinations can help t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gaurav, Amit, Gupta, Varsha, Shrivastava, Sandeep K., Pathania, Ranjana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110569/ https://www.ncbi.nlm.nih.gov/pubmed/33972678 http://dx.doi.org/10.1038/s42003-021-02074-5

Ejemplares similares

Mechanism of Synergy Between Tetracycline and Quercetin Against Antibiotic Resistant Escherichia coli
por: Qu, Shaoqi, et al.
Publicado: (2019)

In vitro synergy of sertraline and tetracycline cannot be reproduced in pigs orally challenged with a tetracycline resistant Escherichia coli
por: Kromann, Sofie, et al.
Publicado: (2019)

Deciphering the virulence factors, regulation, and immune response to Acinetobacter baumannii infection
por: Shadan, Afreen, et al.
Publicado: (2023)

Identification of Novel Regulatory Small RNAs in Acinetobacter baumannii
por: Sharma, Rajnikant, et al.
Publicado: (2014)

Tetracycline resistance mediated by tet efflux pumps in clinical isolates of Acinetobacter baumannii
por: Beheshti, Maryam, et al.
Publicado: (2020)

Binding of Tetracyclines to Acinetobacter baumannii TetR Involves Two Arginines as Specificity Determinants
por: Sumyk, Manuela, et al.
Publicado: (2021)

Rescuing Tetracycline Class Antibiotics for the Treatment of Multidrug-Resistant Acinetobacter baumannii Pulmonary Infection
por: De Oliveira, David M. P., et al.
Publicado: (2022)

The Outer Membrane Proteins OmpA, CarO, and OprD of Acinetobacter baumannii Confer a Two-Pronged Defense in Facilitating Its Success as a Potent Human Pathogen
por: Uppalapati, Siva R., et al.
Publicado: (2020)

Molecular characterization of carbapenem-resistant Escherichia coli and Acinetobacter baumannii in the Lao People’s Democratic Republic
por: Cusack, Tomas-Paul, et al.
Publicado: (2019)

Nalidixic acid and diabetic ketoacidosis
por: Arefi, Mohammad, et al.
Publicado: (2012)

In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant Acinetobacter baumannii
por: Abdul-Mutakabbir, Jacinda C., et al.
Publicado: (2021)

Phenotypic and genotypic characteristics of tetracycline resistant Acinetobacter baumannii isolates from nosocomial infections at Tehran hospitals
por: Maleki, Mohammad Hossein, et al.
Publicado: (2014)

The Transcriptomic Signature of Tigecycline in Acinetobacter baumannii
por: Li, Liping, et al.
Publicado: (2020)

Toward Repurposing Ciclopirox as an Antibiotic against Drug-Resistant Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae
por: Carlson-Banning, Kimberly M., et al.
Publicado: (2013)

Distribution and characterization of ampicillin- and tetracycline-resistant Escherichia coli from feedlot cattle fed subtherapeutic antimicrobials
por: Mirzaagha, Parasto, et al.
Publicado: (2011)

Draft Genome Sequence of Escherichia coli O157:H7 ATCC 35150 and a Nalidixic Acid-Resistant Mutant Derivative
por: Markell, James A., et al.
Publicado: (2015)

Insight into synergetic mechanisms of tetracycline and the selective serotonin reuptake inhibitor, sertraline, in a tetracycline-resistant strain of Escherichia coli
por: Li, Lili, et al.
Publicado: (2017)

Insights into Acinetobacter baumannii protective immunity
por: Jeffreys, Sean, et al.
Publicado: (2022)

Synergy effect of meropenem-based combinations against Acinetobacter baumannii: a systematic review and meta-analysis
por: Jiang, Zhihui, et al.
Publicado: (2018)

Surprising synergy of dual translation inhibition vs. Acinetobacter baumannii and other multidrug-resistant bacterial pathogens
por: Dillon, Nicholas, et al.
Publicado: (2019)

Clonal dissemination of Salmonella enterica serovar albany with concurrent resistance to ampicillin, chloramphenicol, streptomycin, sulfisoxazole, tetracycline, and nalidixic acid in broiler chicken in Korea
por: Wei, Bai, et al.
Publicado: (2021)

Mechanistic insight into how multidrug resistant Acinetobacter baumannii response regulator AdeR recognizes an intercistronic region
por: Wen, Yurong, et al.
Publicado: (2017)

Global responses to oxytetracycline treatment in tetracycline-resistant Escherichia coli
por: Møller, Thea S. B., et al.
Publicado: (2020)

Tackling Acinetobacter baumannii
por: Granata, Guido, et al.
Publicado: (2023)

Pharmacokinetic-pharmacodynamic modelling to investigate in vitro synergy between colistin and fusidic acid against MDR Acinetobacter baumannii
por: Phee, Lynette M, et al.
Publicado: (2019)

Genetic synergy in Acinetobacter baumannii undecaprenyl biosynthesis and maintenance of lipid asymmetry impacts outer membrane and antimicrobial resistance
por: Noel, Hannah R., et al.
Publicado: (2023)

Antibacterial Activity of Methyl Gallate Isolated from Galla Rhois or Carvacrol Combined with Nalidixic Acid Against Nalidixic Acid Resistant Bacteria
por: , Jang-Gi Choi, et al.
Publicado: (2009)

Evaluation of Ciprofloxacin (gyrA, parC Genes) and Tetracycline (tetB Gene) Resistance in Nosocomial Acinetobacter baumannii Infections
por: Nowroozi, Jamileh, et al.
Publicado: (2014)

Manure Compost Is a Potential Source of Tetracycline-Resistant Escherichia coli and Tetracycline Resistance Genes in Japanese Farms
por: Yoshizawa, Nobuki, et al.
Publicado: (2020)

Draft Genome Sequences of a Ceftazidime-Resistant Acinetobacter baumannii Donor and a Conjugal Escherichia coli Recipient with Acquired Resistance
por: Chen, Hongjie, et al.
Publicado: (2019)

When Combined with Colistin, an Otherwise Ineffective Rifampicin–Linezolid Combination Becomes Active in Escherichia coli, Pseudomonas aeruginosa, and Acinetobacter baumannii
por: Armengol, Eva, et al.
Publicado: (2020)

Epidemiology and mortality outcome of carbapenem- and colistin-resistant Klebsiella pneumoniae, Escherichia coli, Acinetobacter baumannii, and Pseudomonas aeruginosa bloodstream infections
por: Balkhair, A., et al.
Publicado: (2023)

Mutation-based fluoroquinolone resistance in carbapenem-resistant Acinetobacter baumannii and Escherichia coli isolates causing catheter-related bloodstream infections
por: Tawfick, Mahmoud M., et al.
Publicado: (2023)

Antimicrobial Efficacy and Synergy of Metal Ions against Enterococcus faecium, Klebsiella pneumoniae and Acinetobacter baumannii in Planktonic and Biofilm Phenotypes
por: Vaidya, Misha Y., et al.
Publicado: (2017)

Multidrug-Resistant Acinetobacter baumannii
por: Abbo, Aharon, et al.
Publicado: (2005)

Multidrug-Resistant Acinetobacter baumannii
por: Krcmery, Vladimir, et al.
Publicado: (2007)

Diagnosis of Acinetobacter Baumannii Infections
por: Gozdas, Hasan T
Publicado: (2012)

Acinetobacter baumannii—The New MRSA?
por: Barrie, Alasdair, et al.
Publicado: (2016)

Glycosphingolipids Recognized by Acinetobacter baumannii
por: Madar Johansson, Miralda, et al.
Publicado: (2020)

Subunit vaccines for Acinetobacter baumannii
por: Yang, Ning, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_irp1mckjlldem421sb478frtqi